XERS XERIS BIOPHARMA HOLDINGS INC
2026Q1 · CUSIP 98422E103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
229
Δ holders QoQ
+5
Breadth percentile
Top 43%
Whale holders
113
Δ whales
0
Inst. holding value
$543M
New positions
42
Closed positions
37
Price momentum (1Q)
-13.0%
Put / Call
4/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 10% | -7.3% | -14.2% |
| 2025Q1 | Top 4% | +51.1% | +49.1% |
| 2024Q1 | Top 13% | +37.4% | +47.5% |
| 2023Q2 | Top 18% | -28.1% | +47.9% |
| 2022Q1 | Top 16% | -23.6% | -42.6% |
| 2021Q4 | Top 5% | -18.3% | -30.6% |
Options Sentiment
Put holders
4
QoQ: +2
Call holders
5
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
117.9
EPS (TTM)
$0.07
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
+41.5%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)